Heart Valve Disease clinical trials at UCLA
1 research study open to eligible people
Showing trials for
EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
open to eligible people ages 18 years and up
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
Los Angeles, California and other locations
Our lead scientists for Heart Valve Disease research studies include Olcay Aksoy, MD.
Last updated: